Collectively, these findings demonstrate that ZGE modulates multiple stress‐responsive pathways in tumor tissues, attenuating oxidative damage (via TRPM2 and SOD2), amplifying inflammatory signaling (via TNF‐α), and promoting apoptosis (via caspase‐3), particularly when combined with DOX treatment. The gene discussed is SOD2; the disease is neoplasm.